Type
Internal restructuring
Country
Germany
Region
Nordrhein-Westfalen;
Location of affected unit(s)
Leverkusen, Wuppertal
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.10 - Manufacture of basic pharmaceutical products

4,150 jobs
Number of planned job losses
Job loss
Announcement Date
9 April 2019
Employment effect (start)
9 April 2019
Foreseen end date
9 April 2021

Description

The pharmaceutical manufacturer Bayer announced the loss of 4,500 jobs in Germany due to internal restructuring. The job reduction comes as part of a worldwide savings programme, announced in December 2018, which intends to save €1.4 billion and includes the loss of 12,000 employees until 2021. According to the CEO, Bayer’s headquarter will mainly be affected with the loss of approximately 4,000 jobs. Additionally, the plant in Wuppertal will be affected with the loss of minimum 350 jobs. Mainly affected will be jobs in service, IT and operative purchasing. Compulsory redundancies are collectively excluded until 2025. Bayer will be reliant on voluntary solutions such as early-retirement programmes.

Currently, Bayer has 32,140 employees in Germany.


Sources

Citation

Eurofound (2019), Bayer, Internal restructuring in Germany, factsheet number 97566, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/97566.